top of page
Supported projects
Oncoshift
Oncoshift develops first-in-class molecules targeting metabolic adaptation to ensure a durable anti-cancer response.
PSCC's entrance
Septembre 2026
Localization
FR - Auvergne-Rhône-Alpes
Modality
Small Molecules/chemotherapy
Development status
Biotech – Pre-IND/Pre-CTA
Award(s)
iLAB
bottom of page